HomeTVTX • NASDAQ
add
Travere Therapeutics Inc
Previous close
$15.23
Day range
$14.02 - $15.58
Year range
$5.12 - $15.58
Market cap
1.17B USD
Avg Volume
2.12M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 54.12M | 68.08% |
Operating expense | 64.78M | -5.02% |
Net income | -70.41M | 17.78% |
Net profit margin | -130.11 | 51.08% |
Earnings per share | -0.65 | 15.58% |
EBITDA | -56.71M | 39.03% |
Effective tax rate | -0.12% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 325.40M | -33.77% |
Total assets | 551.12M | -25.16% |
Total liabilities | 535.97M | -13.54% |
Total equity | 15.15M | — |
Shares outstanding | 76.49M | — |
Price to book | 76.15 | — |
Return on assets | -27.60% | — |
Return on capital | -37.40% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -70.41M | 17.78% |
Cash from operations | -40.24M | 41.93% |
Cash from investing | 28.61M | 221.47% |
Cash from financing | 782.00K | -65.49% |
Net change in cash | -10.96M | 87.89% |
Free cash flow | -156.01M | -207.70% |
About
Founded
2008
Website
Employees
380